Cowen downgraded Tattooed Chef from Outperform to Market Perform and set a new price target of $4.50 from $10.00 previously
Save time and jump to the most important pieces.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 10/24/2022 | $10.00 → $4.50 | Outperform → Market Perform | Cowen |
| 9/30/2022 | $6.00 | Neutral | UBS |
| 8/9/2022 | $12.00 → $9.00 | Buy → Neutral | ROTH Capital |
| 12/8/2021 | $24.00 | Outperform | Cowen & Co. |
PARAMOUNT, Calif., Jan. 14, 2021 (GLOBE NEWSWIRE) -- Tattooed Chef, Inc. (Nasdaq: TTCF, TTCFW) (“Tattooed Chef” or the “Company”), a leader in plant-based foods, today announced that the Company will redeem all of its outstanding publicly held warrants (the “Public Warrants”) that remain unexercised immediately after 5:00 p.m. New York City time on February 16, 2021, the date for redemption fixed by the Company. Under the terms of the warrant agreement governing the public warrants (the “Warrant Agreement”), the Company is entitled to redeem all of the outstanding public warrants if the last sales price of the Company’s common stock is at least $18.00 per share on each of twenty trading da
SC 13G/A - Tattooed Chef, Inc. (0001741231) (Subject)
SC 13G/A - Tattooed Chef, Inc. (0001741231) (Subject)
SC 13D/A - Tattooed Chef, Inc. (0001741231) (Subject)
4 - Tattooed Chef, Inc. (0001741231) (Issuer)
4 - Tattooed Chef, Inc. (0001741231) (Issuer)
4 - Tattooed Chef, Inc. (0001741231) (Issuer)
Cowen downgraded Tattooed Chef from Outperform to Market Perform and set a new price target of $4.50 from $10.00 previously
UBS initiated coverage of Tattooed Chef with a rating of Neutral and set a new price target of $6.00
ROTH Capital downgraded Tattooed Chef from Buy to Neutral and set a new price target of $9.00 from $12.00 previously
PARAMOUNT, Calif., June 30, 2023 (GLOBE NEWSWIRE) -- Tattooed Chef, Inc. (NASDAQ:TTCF) ("Tattooed Chef" or the "Company"), a leader in plant-based foods, announced today that it intends to file for protection under Chapter 11 of the U.S. Bankruptcy Code ("Bankruptcy Code") in the United States Bankruptcy Court for the Central District of California ("Bankruptcy Court") and intends to pursue a sale of substantially all of its assets under Section 363 of the Bankruptcy Code. In accordance with the sale process under Section 363 of the Bankruptcy Code, the Company will market its assets and solicit competing bids from interested parties. The bidding process is designed to achieve the highest
Provides Progress on Previously Announced Cost Reduction Initiatives and Updates Outlook Announces Filing of 2022 Form 10-K and 2023 First Quarter Form 10-Q PARAMOUNT, Calif., May 15, 2023 (GLOBE NEWSWIRE) -- Tattooed Chef, Inc. (NASDAQ:TTCF) ("Tattooed Chef" or the "Company"), a leader in plant-based foods, today announced financial results for the first quarter ended March 31, 2023 ("Q1 2023"). The Company also announced that it has filed its Annual Report on Form 10-K for the year ended December 31, 2022 and its Quarterly Report on Form 10-Q for the period ended March 31, 2023 with the Securities and Exchange Commission. The Company also provided an update on its previously announce
PARAMOUNT, Calif., April 05, 2023 (GLOBE NEWSWIRE) -- Tattooed Chef, Inc. (NASDAQ:TTCF) ("Tattooed Chef" or the "Company"), a leader in plant-based foods, announced today that it received a letter (the "Notification Letter") on March 31, 2023 from The Nasdaq Stock Market, LLC ("Nasdaq") informing the Company that it was not in compliance with Nasdaq Listing Rule 5250(c)(1), which requires listed companies to timely file all required periodic financial reports with the Securities and Exchange Commission ("SEC"), due to the Company's failure to timely file its Annual Report on Form 10-K for the fiscal year ended December 31, 2022 (the "Form 10-K"). The notification letter has no immediate ef
Provides Progress on Previously Announced Cost Reduction Initiatives and Updates Outlook Announces Filing of 2022 Form 10-K and 2023 First Quarter Form 10-Q PARAMOUNT, Calif., May 15, 2023 (GLOBE NEWSWIRE) -- Tattooed Chef, Inc. (NASDAQ:TTCF) ("Tattooed Chef" or the "Company"), a leader in plant-based foods, today announced financial results for the first quarter ended March 31, 2023 ("Q1 2023"). The Company also announced that it has filed its Annual Report on Form 10-K for the year ended December 31, 2022 and its Quarterly Report on Form 10-Q for the period ended March 31, 2023 with the Securities and Exchange Commission. The Company also provided an update on its previously announce
PARAMOUNT, Calif., Nov. 15, 2022 (GLOBE NEWSWIRE) -- Tattooed Chef, Inc. (NASDAQ:TTCF) ("Tattooed Chef" or the "Company"), a leader in plant-based foods, today announced financial results for the third quarter ended September 30, 2022 ("Q3 2022"). Third Quarter 2022 Financial Overview Compared to Third Quarter 2021 Net revenue of $54.1 million compared to $58.0 millionGross loss of $(3.9) million, or gross margin of (7.2)%, compared to gross profit of $5.0 million, or gross margin of 8.6%Net loss of $38.5 millionAdjusted EBITDA loss (1) of $25.5 million(1) Adjusted EBITDA is a non-GAAP financial measure as defined below under "Non-GAAP Measures." Please see "Adjusted EBITDA Reconcili
PARAMOUNT, Calif., Nov. 15, 2022 (GLOBE NEWSWIRE) -- Tattooed Chef, Inc. (NASDAQ:TTCF) ("Tattooed Chef" or the "Company"), a leader in plant-based foods, today announced it will report financial results for the third quarter ended September 30, 2022 on Tuesday, November 15, 2022 after the close of the stock market. The Company will host a conference call that same day at 5:00 p.m. Eastern Time to discuss the results. Investors interested in participating in the live call can dial: 877-407-9753 (Domestic)201-493-6739 (International) The call will be webcast and available on the Investors section of the Company's website at www.tattooedchef.com. The webcast will be archived for 30 days.
8-K - Tattooed Chef, Inc. (0001741231) (Filer)
8-K - Tattooed Chef, Inc. (0001741231) (Filer)
8-K - Tattooed Chef, Inc. (0001741231) (Filer)
Gainers CytoMed Therapeutics Limited (NASDAQ:GDTC) shares climbed 129.5% to $8.01 after gaining 9% on Monday. Adial Pharmaceuticals, Inc. (NASDAQ:ADIL) gained 58.2% to $0.32 after the company issued a business update following favorable comments from US and EU regulatory meetings. SOS Limited (NYSE:SOS) climbed 49.2% to $8.52. Better Therapeutics, Inc. (NASDAQ:BTTX) shares climbed 42.2% to $1.2805 after the FDA approved the company's AspyreRx (formerly BT-001), a prescription-only digital treatment to provide cognitive behavioral therapy to adult patients with type 2 diabetes. Taoping Inc. (NASDAQ:TAOP) gained 34.4% to $0.7099. Taoping posted 1H contract revenue of $14.65 million, up
Gainers CytoMed Therapeutics Limited (NASDAQ:GDTC) shares surged 109.2% to $7.30 in pre-market trading after gaining 9% on Monday. Better Therapeutics, Inc. (NASDAQ:BTTX) shares gained 51.1% to $1.36 in pre-market trading after the FDA approved the company's AspyreRx prescription-only digital therapeutic treatment to provide cognitive behavioral therapy to adult patients with type 2 diabetes. Crown ElectroKinetics Corp. (NASDAQ:CRKN) shares rose 42.2% to $0.1450 in pre-market trading after declining around 14% on Monday. Trinity Place Holdings Inc. (NYSE:TPHS) gained 24.1% to $0.6790 in pre-market trading after declining around 15% on Monday. TC Biopharm (Holdings) Plc (NASDAQ:TCBP
On Monday, 65 companies hit new 52-week lows. Things to Consider About Today's 52-Week Lows: The largest company by market cap to set a new 52-week low was Pfizer (NYSE:PFE). The smallest company in terms of market cap to set a new 52-week low was Biodexa Pharmaceuticals (NASDAQ:BDRX). Tivic Health Systems (NASDAQ:TIVC) shares traded down 40.69% to reach its 52-week low, making it the biggest loser. Chijet Motor Co (NASDAQ:CJET) shares bounced back the most, actually rising 0.0% after hiting a new 52-week low. Stocks dropping to new 52-week lows on Monday: Bristol-Myers Squibb (NYSE:BMY) shares fell to $62.30 on Monday, setting a new 52-week low with a shift of down 0.54%. Hu